Eric Siegel

Eric Siegel has extensive experience in compliance and legal roles within the pharmaceutical and healthcare sectors. Notable positions include Vice President and Head of Compliance at Idorsia Pharmaceuticals US Inc. and Chief Compliance Officer at Jazz Pharmaceuticals, where responsibilities included developing and implementing Corporate Compliance Programs and negotiating a Corporate Integrity Agreement with the US Department of Health and Human Services Office of Inspector General. Eric Siegel has also served in several legal and compliance leadership roles at organizations such as Incyte, EMD Serono, Solstice Neurosciences, and Cephalon. Educational qualifications include a JD from the University of Pennsylvania Carey Law School, an MBA in Health Administration from the Fox School of Business at Temple University, and a BA in Chemistry from Franklin & Marshall College.